openPR Logo
Press release

Continuous Peripheral Nerve Block Catheter (CPNBC) Market increase at 6% CAGR during the forecast period 2016-2026

06-05-2017 09:43 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Continuous Peripheral Nerve Block Catheter (CPNBC) Market

Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016.

Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue to fuel growth of the market in 2016. Other factors, such as cost-effectiveness and lower hospital stay are also making continuous peripheral never block catheters an appealing option for analgesia among healthcare professionals. However, longstanding challenges, such as lack of trained professionals and ambiguity over standard usage guidelines are anticipated to pose challenges to widespread adoption.

Request For Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1307

The U.S. will continue to be at the forefront of adoption of continuous peripheral nerve block catheters, making North America the most lucrative market globally. North America’s revenue share in the global CPNBC market is expected to reach 42.4% in 2016. Western Europe is the second-largest market, with total revenues reaching US$ 61.3 Mn in 2016.

By product, non-stimulating catheter systems account for the highest demand—in 2016, global revenues are anticipated to total US$ 220.8 Mn. On the other hand, the over-the-needle product segment will witness lowest demand in 2016 and beyond.

By insertion technique, ultrasound insertion is gaining traction over nerve stimulation although the latter accounts for the majority revenue share of the market currently. Ultrasound insertion revenues are anticipated to grow by 5.8% in 2016, whereas over nerve stimulation revenues will grow by 4.5%.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1307

By indication, lower extremity surgeries will continue to be the leading segment, accounting for US$ 119.8 Mn in 2016, an increase of 5.3% over 2015. Adoption of CPNBC in lower extremity surgeries is anticipated to be quite robust, and this segment will witness higher growth than other indication segments.

By end-user, hospitals will continue to maintain their dominance over ambulatory surgical centres in 2016 as well. The hospitals segment of the continuous peripheral nerve block catheters market is expected to reach US$ 243.4 Mn in revenues in 2016, witness a growth of 5.3% over 2015.

B.Braun Melsungen AG is the largest player in the continuous peripheral nerve block cathether market. It has a broad product portfolio and its products have been positively received in the market. Other key players in the market include Halyard Health, Inc., Ambu A/S, Epimed International Inc., Teleflex Incorporated, and Pajunk GmbH.

Long-term Outlook: The global continuous peripheral nerve block catheters market is anticipated to increase at 6% CAGR during the forecast period 2016-2026. North America will continue to be the largest market, whereas rising awareness will led to higher adoption in developing countries.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press: press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Peripheral Nerve Block Catheter (CPNBC) Market increase at 6% CAGR during the forecast period 2016-2026 here

News-ID: 563001 • Views:

More Releases from Future Market Insights

Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% CAGR and Rising Demand for Carotenoids and Omega Compounds
Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% …
The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million by 2035
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million …
The global grapeseed oil market is projected to grow from USD 541.5 million in 2025 to USD 809.3 million by 2035, registering a CAGR of 4.1%. Rising demand across culinary, personal care, and nutraceutical applications is elevating its market value due to its rich antioxidant profile, vitamin E content, and plant-based origin. Health-conscious consumers are increasingly choosing grapeseed oil for premium cooking and natural skincare, while manufacturers expand cold-pressing capacities to
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by 7.8% CAGR
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by …
The global soybean enzymatic protein market is moving into a phase of rapid commercial adoption, projected to expand from USD 2.4 billion in 2025 to USD 5.2 billion by 2035, registering a CAGR of 7.8%. What began as a niche application segment during 2020-2024 has now matured into a scalable, mainstream protein category integrated into beverages, functional foods, meat alternatives, and nutritional supplements. Between 2025 and 2030, the market enters its
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growth
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growt …
The global squid market, valued at USD 12.7 billion in 2025, is projected to reach USD 18.4 billion by 2035, reflecting a 3.8% CAGR, driven by rising seafood demand, diversified product formats, and robust food supply chains. Steady consumption growth across Asia-Pacific, Europe, and North America continues to uplift commercial fishing, aquaculture, and value-added squid processing. Growth momentum between 2021 and 2025 shows a consistent upward curve, with the market expanding

All 5 Releases


More Releases for CPNBC

Continuous Peripheral Nerve Block Catheter (CPNBC) Market Will hit at a CAGR of …
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue
Continuous Peripheral Nerve Block Catheter (CPNBC) Market to Grow at a CAGR of 6 …
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue
Continuous Peripheral Nerve Block Catheter (CPNBC) Market to Expand at a CAGR of …
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue
Continuous Peripheral Nerve Block Catheter (CPNBC) Market will Increase at a CAG …
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue
Continuous Peripheral Nerve Block Catheters Market to Grow by 4.9% in 2016
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue
continuous peripheral nerve block catheters market is anticipated to increase at …
Continuous peripheral nerve block catheters are gaining traction in the healthcare sector as an effective analgesic for pain management. The global market for continuous peripheral never block catheters (CPNBC) was valued at US$ 372.8 Mn in 2015, and is expected to witness a year-over-year growth of 4.9% to reach US$ 391.2 Mn in 2016. Increasing prevalence of osteoarthritis and effectiveness of CPNBC in upper/lower extremity joint replacement procedures will continue